Cellromax Science Co., Ltd. (KOSDAQ:471820)
3,945.00
-335.00 (-7.83%)
At close: Jul 20, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 44.88 billion as of July 21, 2026. Its market cap has decreased by -33.20% in one year.
Market Cap
44.88B
Enterprise Value
36.00B
Revenue
20.98B
Ranking
n/a
PE Ratio
13.45
Stock Price
3,945.00
ChartMarket Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 44.88B, a decrease of -51.58%. That is a compound annual growth rate of -36.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 43.56B | -40.80% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HBL Corporation | 82.40B |
| GFI Co., Ltd. | 76.44B |
| Black Yak I&C Co.,Ltd | 66.80B |
| KP Aero Industries | 58.26B |
| GITSN | 58.06B |
| NBR Motion | 55.98B |
| ERCOHS Agricultural Corporation Co.,Ltd | 52.33B |
| Laseroptek | 40.90B |